• Citer

Analysis of regional timelines to set up a global phase III clinical trial in breast cancer: The adjuvant lapatinib and/or trastuzumab treatment optimization experience

par Metzger-Filho, Otto;de Azambuja, Evandro ;Bradbury, Ian;Saini, Kamal ;Bines, Jose;Simon, Sergio;van Dooren, Veerle;Aktan, Gursel;Pritchard, Kathleen;Wolff, Antonio C;Smith, Ian;Jackisch, Christian;Lang, Istvan;Untch, Michael;Boyle, Frances;Xu, Binghe;Baselga, José;Perez, Edith A;Piccart-Gebhart, Martine
Référence The oncologist, 18, 2, page (134-140)
Publication Publié, 2013

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Analysis of regional timelines to set up a global phase III clinical trial in breast cancer: The adjuvant lapatinib and/or trastuzumab treatment optimization experience
Auteur:	Metzger-Filho, Otto; de Azambuja, Evandro; Bradbury, Ian; Saini, Kamal; Bines, Jose; Simon, Sergio; van Dooren, Veerle; Aktan, Gursel; Pritchard, Kathleen; Wolff, Antonio C; Smith, Ian; Jackisch, Christian; Lang, Istvan; Untch, Michael; Boyle, Frances; Xu, Binghe; Baselga, José; Perez, Edith A; Piccart-Gebhart, Martine
Informations sur la publication:	The oncologist, 18, 2, page (134-140)
Statut de publication:	Publié, 2013
Sujet CREF:	Cancérologie
Mots-clés:	Activation
	Ethics committee/institutional review board
	Phase III clinical trials
MeSH keywords:	Antibodies, Monoclonal, Humanized -- administration & dosage -- therapeutic use
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Breast Neoplasms -- drug therapy -- pathology
	Clinical Trials, Phase III as Topic -- methods
	Female
	Humans
	International Cooperation
	Multicenter Studies as Topic -- methods
	Quinazolines -- administration & dosage
	Randomized Controlled Trials as Topic -- methods
	Time Factors
Note générale:	SCOPUS: re.j
Langue:	Anglais
Identificateurs:	urn:issn:1083-7159
	info:doi/10.1634/theoncologist.2012-0342
	info:pii/theoncologist.2012-0342
	info:scp/84874350918
	info:pmid/23359433
	PMC3579596